Par Pharmaceutical Cos., Inc. (PRX) Tops Q3 EPS by 1c, Sales Miss Expectations
Tweet Send to a FriendGet Alerts PRX Hot Sheet
Price: $49.98 --0%
EPS Growth %: +92.9%
Financial Fact:
Income (loss) from continuing operations: -0.79
Today's EPS Names:
MPAA, LTON, KFY, More
EPS Growth %: +92.9%
Financial Fact:
Income (loss) from continuing operations: -0.79
Today's EPS Names:
MPAA, LTON, KFY, More
Trade PRX Now!
Par Pharmaceutical Cos., Inc. (NYSE: PRX) reported Q3 non-GAAP EPS of $0.74, $0.01 better than the analyst estimate of $0.73. Revenue for the quarter came in at $215.4 million versus the consensus estimate of $309.97 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- PVH Corp. (PVH) Tops Q1 EPS by 56c; Issues Q2 EPS, Revs Outlook
- VisionChina Media, Inc. (VISN) Reports Q1 Loss of $2.87
- Mens Wearhouse (MW) Reports Q1 EPS of $0.65, Offers Guidance
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
